Respiratory inhaler devices are essential tools for delivering medication directly into the lungs for the treatment and management of respiratory conditions such as asthma, chronic obstructive ...

Dublin, Dec. 21, 2020 (GLOBE NEWSWIRE) -- The "Global Respiratory Inhaler Devices Market (2020-2025) by Product, Technology, End-User, Disease Indication and Geography and the Impact of Covid-19 with ...

Rural hospitals made up a larger share of 2026 layoffs as closures slowed. About 720 rural hospitals remain at risk of closing, raising access concerns. If Passed, Idaho's Proposition 1 Would Allow ...

Key drivers include developments in smart and sustainable designs. The respiratory inhaler devices market is expected to reach $51.9b by 2034 at a compound annual growth rate (CAGR) of 4.8%, according ...

When you ask, 'Are you using it every day?', the patient nods. The remaining medication count is not significantly off, ...

LONDON (Reuters) - Makers of inhalers to treat asthma and chronic lung disease are racing to develop a new generation of smart devices with sensors to monitor if patients are using their puffers ...

Just 24.7% of elderly patients with chronic obstructive pulmonary disease (COPD) included in the study demonstrated correct usage of their inhaler. Despite all 200 patients included in the study being ...

Inhalers are the mainstay of treatment for asthma and chronic obstructive pulmonary disease (COPD). These products face limited generic competition in the US and remain expensive. To better understand ...

According to Fortune Business Insights, the global smart inhaler market size was valued at USD 221.98 million in 2025 and is ...

PHILADELPHIA, Pennsylvania — A simple handheld training device doubles the likelihood that patients with asthma will achieve the correct inspiratory flow when using their medication inhalers. After ...